PAVmed (PAVM) Interest Expenses (2016 - 2025)

PAVmed's Interest Expenses history runs 10 years deep, the most recent figure standing at -$5000.0 for Q4 2025.

• On a quarterly basis, Interest Expenses fell 171.43% year-over-year to -$5000.0 in Q4 2025; TTM through Dec 2025 was $539000.0, a 49.48% decrease from a year earlier, with the FY2025 full-year figure at $34.2 million, down 18.53% from the prior year.
• Interest Expenses fell to -$5000.0 in Q4 2025 per PAVM's latest filing, from $530000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $45.3 million in Q3 2021 and bottomed at -$5000.0 in Q4 2025.
• The 5-year median for Interest Expenses is $577000.0 (2024), against an average of $5.6 million.
• Across the five-year window, Interest Expenses jumped 2732.73% in 2021 and sank 171.43% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $3.5 million in 2021, then slumped by 85.27% to $518000.0 in 2022, then tumbled by 96.33% to $19000.0 in 2023, then plunged by 63.16% to $7000.0 in 2024, then tumbled by 171.43% to -$5000.0 in 2025.
• Per Business Quant, the three latest PAVM Interest Expenses figures stand at -$5000.0 (Q4 2025), $530000.0 (Q3 2025), and $484000.0 (Q2 2025).